Faes Farma revenue and financials
€4.75Change from previous close: 0.00%
In the fiscal year ended December 2025, Faes Farma reported revenue of €610.46M (+23.66% year over year). Net income was €79.63M, a net margin of 13.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +23.66%
- 2025 vs 2024
- Net income growth
- −28.49%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 22.6%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q4 2025 | Q2 2025 |
|---|---|---|
| Total assets | 1,342 | 1,000 |
| Current assets | 482 | 423 |
| Cash and equivalents | 117 | 103 |
| Short-term investments | 12.8 | 8.3 |
| Inventory | 183 | 155 |
| Net property, plant and equipment | 353 | 318 |
| Goodwill | 258 | 103 |
| Other intangible assets | 199 | 126 |
| Current liabilities | 185 | 184 |
| Accounts payable | 83.4 | 33.6 |
| Long-term debt | 374 | 63.6 |
| Total debt | 426 | 95.7 |
| Total liabilities | 596 | 270 |
| Total equity (incl. minority) | 746 | 730 |
| Retained earnings | 195 | 52.3 |
| Minority interest | 0.8 | 0.6 |